1. Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up;Hendriks;Ann Oncol,2023
2. ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer;Passaro;Ann Oncol,2022
3. Therapy for stage IV non–small-cell lung cancer without driver alterations: ASCO and OH (CCO) joint guideline update;Hanna;J Clin Oncol,2020
4. Aisner DL, Akerley W, Bauman JR, et al. NCCN guidelines version 5.2022 non-small cell lung cancer continue NCCN guidelines panel disclosures. 2022. Available at National Comprehensive Cancer Network. Non-Small Cell Lung Cancer (Version 3.2023). https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf. Accessed June 13, 2023.
5. Lung cancer biomarker testing: perspective from Europe;Thunnissen;Transl Lung Cancer Res,2020